Sun Pharma/SID Innovation Research...
1
Rafik Boudra, PhD Brigham and Women’s Hospital, Harvard Institute of Medicine, Boston, MA Dr. Boudra completed his PhD in Physiology and Molecular Genetics in 2015 in France, working specifically on the physiopathology of prostate cancer. He then joined the Ramsey Laboratory at the Brigham and Women’s Hospital (Boston, MA) to continue his training as a postdoc. He is currently studying the role(s) of the transcription factor BNC1 in the physiology of normal skin and in the initiation, maintenance and progression of squamous cell carcinoma. Erin Brettman, PhD Washington University in St. Lous, St. Louis, WA Dr. Brettman received her PhD in Molecular Cell Biology from Washington University in St. Louis in 2017. She is currently a postdoc in the lab of Dr. Cristina de Guzman Strong, where she is investigating population-specific genetic modulators of skin barrier integrity. Sanjana P. Devi Kangabam, PhD Weill Cornell Medicine, New York, NY Dr. Kangabam is a skilled immunologist with a background in glycobiology, cellular immunology and cancer immunotherapy. Her research area has been focused on identifying a novel role for regional PDL1/2-PD1 DC:T cell cross talk, in the regulation of skin specific memory T cells formation and recall activity. She further aims to understand the critical molecular pathways limiting skin inflammation, as well as mechanisms that lead to contraction of the immune response to skin cancer. Robert Dorschner, MD University of California, San Diego, San Diego, CA Dr. Dorschner is an active researcher and clinician at the University of California, San Diego, where he previously completed his MD and Dermatology residency training. His earlier research examined the role of antimicrobial peptides in the cutaneous innate immune system and he is currently using the wound as a model to understand how inflammation is mediated in response to injury. He is looking forward to continuing this work with the generous support of the Sun Pharma - SID Innovation Fellowship. Sun Pharma/SID Innovation Research Fellowships Congratulations to the following recipients who each received a $50,000 Sun Pharma/SID Innovation Research Fellowship.
Transcript of Sun Pharma/SID Innovation Research...
Rafik Boudra, PhDBrigham and Women’s Hospital, Harvard Institute of Medicine, Boston, MA
Dr. Boudra completed his PhD in Physiology and Molecular Genetics in 2015 in France, working specifically on the physiopathology of prostate cancer. He then joined the Ramsey Laboratory at the Brigham and Women’s Hospital (Boston, MA) to continue his training as a postdoc. He is currently studying the role(s) of the transcription factor BNC1 in the physiology of normal skin and in the initiation, maintenance and progression of squamous cell carcinoma.
Erin Brettman, PhDWashington University in St. Lous, St. Louis, WA
Dr. Brettman received her PhD in Molecular Cell Biology from Washington University in St. Louis in 2017. She is currently a postdoc in the lab of Dr. Cristina de Guzman Strong, where she is investigating population-specific genetic modulators of skin barrier integrity.
Sanjana P. Devi Kangabam, PhDWeill Cornell Medicine, New York, NY
Dr. Kangabam is a skilled immunologist with a background in glycobiology, cellular immunology and cancer immunotherapy. Her research area has been focused on identifying a novel role for regional PDL1/2-PD1 DC:T cell cross talk, in the regulation of skin specific memory T cells formation and recall activity. She further aims to understand the critical molecular pathways limiting skin inflammation, as well as mechanisms that lead to contraction of the immune response to skin cancer.
Robert Dorschner, MDUniversity of California, San Diego, San Diego, CA
Dr. Dorschner is an active researcher and clinician at the University of California, San Diego, where he previously completed his MD and Dermatology residency training. His earlier research examined the role of antimicrobial peptides in the cutaneous innate immune system and he is currently using the wound as a model to understand how inflammation is mediated in response to injury. He is looking forward to continuing this work with the generous support of the Sun Pharma - SID Innovation Fellowship.
Sun Pharma/SID Innovation Research FellowshipsCongratulations to the following recipients who each received a $50,000 Sun Pharma/SID Innovation Research Fellowship.
